These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 29669762)
1. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762 [TBL] [Abstract][Full Text] [Related]
2. A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer. von Eyss B; Jaenicke LA; Kortlever RM; Royla N; Wiese KE; Letschert S; McDuffus LA; Sauer M; Rosenwald A; Evan GI; Kempa S; Eilers M Cancer Cell; 2015 Dec; 28(6):743-757. PubMed ID: 26678338 [TBL] [Abstract][Full Text] [Related]
3. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
4. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
5. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
6. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer. Patterson MR; Cogan JA; Cassidy R; Theobald DA; Wang M; Scarth JA; Anene CA; Whitehouse A; Morgan EL; Macdonald A Nat Commun; 2024 Jul; 15(1):5809. PubMed ID: 38987584 [TBL] [Abstract][Full Text] [Related]
8. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells. Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184 [TBL] [Abstract][Full Text] [Related]
9. HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity. Yuan B; Liu J; Shi A; Cao J; Yu Y; Zhu Y; Zhang C; Qiu Y; Luo H; Shi J; Cao X; Xu P; Shen L; Liang T; Zhao B; Feng XH EMBO J; 2023 Feb; 42(4):e111549. PubMed ID: 36598329 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
11. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ. Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063 [TBL] [Abstract][Full Text] [Related]
12. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258 [TBL] [Abstract][Full Text] [Related]
13. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Kim M; Kim T; Johnson RL; Lim DS Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714 [TBL] [Abstract][Full Text] [Related]
15. YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers. Galli GG; Carrara M; Yuan WC; Valdes-Quezada C; Gurung B; Pepe-Mooney B; Zhang T; Geeven G; Gray NS; de Laat W; Calogero RA; Camargo FD Mol Cell; 2015 Oct; 60(2):328-37. PubMed ID: 26439301 [TBL] [Abstract][Full Text] [Related]
16. TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148 [TBL] [Abstract][Full Text] [Related]
17. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073 [TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ at the Roots of Cancer. Zanconato F; Cordenonsi M; Piccolo S Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434 [TBL] [Abstract][Full Text] [Related]
19. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125 [TBL] [Abstract][Full Text] [Related]
20. New insights into the ambivalent role of YAP/TAZ in human cancers. Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]